73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou
Targeting a unique metabolic pathway might starve pancreatic cancer

Targeting a unique metabolic pathway might starve pancreatic cancer

by Nancy Fliesler and Andrea Tamayo,Broad Institute of MIT and HarvardMItochondrial staining (red) and nuclear staining (blue) of abnormal pancreatic ducts from a mouse model of human pancreatic

Targeting a unique metabolic pathway might starve pancreatic cancer

by Nancy Fliesler and Andrea Tamayo,Broad Institute of MIT and HarvardMItochondrial staining (red) and nuclear staining (blue) of abnormal pancreatic ducts from a mouse model of human pancreatic
HPV immunization program cuts pre-cancer rates by more than half

HPV immunization program cuts pre-cancer rates by more than half

by University of British ColumbiaGardasil vaccine and box. Image: WikipediaA school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rat

HPV immunization program cuts pre-cancer rates by more than half

by University of British ColumbiaGardasil vaccine and box. Image: WikipediaA school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rat
Two for the price of one: Mechanistic insights lead to drug repositioning

Two for the price of one: Mechanistic insights lead to drug repositioning

by University of TsukubaMolecular mechanism at a glance. SFN binds with SKP1 to sequester it in cytoplasm,resulting in the obstruction of SCFFBW7 598 complex formation. Oncoproteins including cyc

Two for the price of one: Mechanistic insights lead to drug repositioning

by University of TsukubaMolecular mechanism at a glance. SFN binds with SKP1 to sequester it in cytoplasm,resulting in the obstruction of SCFFBW7 598 complex formation. Oncoproteins including cyc
Factor that doubles the risk of death from breast cancer identified

Factor that doubles the risk of death from breast cancer identified

by Karolinska InstitutetMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at Karolinska Institutet in Sweden have discovered that the ri

Factor that doubles the risk of death from breast cancer identified

by Karolinska InstitutetMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at Karolinska Institutet in Sweden have discovered that the ri
Molecular change to immunotherapy antibody could accelerate immune response to cancer

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)
An unexpected journey reveals a potent way to attack tumors

An unexpected journey reveals a potent way to attack tumors

by Nancy Fliesler,Children's Hospital BostonSenescence inducer CuSO4, which causes ER stress, activates NKp46- and NKG2D-dependent NK killing, but 4-PBA, which induces senescence without ER

An unexpected journey reveals a potent way to attack tumors

by Nancy Fliesler,Children's Hospital BostonSenescence inducer CuSO4, which causes ER stress, activates NKp46- and NKG2D-dependent NK killing, but 4-PBA, which induces senescence without ER
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: Pixabay/CC0 Public DomainThe Mays Cancer Center at The University of Texas Health Science Center at San Antonio rec

Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: Pixabay/CC0 Public DomainThe Mays Cancer Center at The University of Texas Health Science Center at San Antonio rec
Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of
Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi
Presidential panel says high-priced cancer drugs harm patient care

Presidential panel says high-priced cancer drugs harm patient care

by Dennis Thompson, Healthday Reporter(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the P

Presidential panel says high-priced cancer drugs harm patient care

by Dennis Thompson, Healthday Reporter(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the P